| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Calcimedica, Inc. (CALC) has 9 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. CALC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.60M | $1.19M | - | |
| 10% | 1.06M | $787.9K | - | |
| Other | 366.4K | $271.5K | - | |
| CEO | 317.7K | $235.4K | - | |
| Other | 186.0K | $137.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Hebbar Sudarshan71 | Chief Medical Officer | Buy | 5,976 | $2.74 | $16,361.50 | +6.4% | +11.0% | - | |
| Jul 28, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Buy | 1,000 | $3.96 | $3,960.00 | +8.4% | -18.3% | -80.6% | |
| Jul 25, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Sell | 1,000 | $3.65 | $3,650.00 | -100% | -19.2% | -80.0% | |
| Jul 22, 2025 | Roberts Eric W58 | Chief Business Officer | Buy | 1,500 | $3.78 | $5,662.50 | +3.1% | -15.6% | -80.3% | |
| Jul 21, 2025 | Roberts Eric W58 | Chief Business Officer | Buy | 1,500 | $3.37 | $5,055.00 | +3.2% | -8.6% | -79.7% | |
| Jul 21, 2025 | Leheny A. Rachel47 | Chief Executive Officer | Buy | 1,000 | $3.40 | $3,400.00 | +40.0% | -8.6% | -79.7% | |
| Jul 18, 2025 | Wilson Robert N | Director | Buy | 4,500 | $2.87 | $12,915.00 | +1.1% | +8.0% | -75.5% | |
| Jul 18, 2025 | Roberts Eric W58 | Chief Business Officer | Buy | 2,000 | $2.88 | $5,760.00 | +4.5% | +8.0% | -75.5% | |
| Jul 14, 2025 | Roberts Eric W58 | Chief Business Officer | Buy | 6,500 | $2.43 | $15,809.95 | +17.2% | +40.5% | -67.9% | |
| Jul 14, 2025 | Leheny A. Rachel47 | Chief Executive Officer | Buy | 2,500 | $2.47 | $6,175.00 | New | +40.5% | -67.9% |